Emergent BioSolutions EBS
NYSE EBS
$6.76 +0.21 (+3.21%)
At close: Sep 22, 2026 · 4:00 PM EDT

Emergent BioSolutions (EBS) Sales of Property, Plant and Equipment (2012 - 2026)

Analysis

Emergent BioSolutions (EBS) Sales of Property, Plant and Equipment (2012 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PP&E (Sale) (Qtr)
1 Johnson & Johnson 649.47 Bn 628.71 Bn 17.26 Bn 63.00 Mn
2 AbbVie 467.46 Bn 460.93 Bn 12.70 Bn -
3 Merck 369.31 Bn 362.22 Bn 12.21 Bn -
4 Novartis Ag 269.03 Bn 261.74 Bn 11.24 Bn 26.00 Mn
5 Pfizer 158.11 Bn 146.71 Bn 10.94 Bn -
6 Bristol Myers Squibb 127.96 Bn 116.89 Bn 9.25 Bn -
7 Sanofi 51.83 Bn 44.86 Bn 10.79 Bn 363.82 Mn
8 BeOne Medicines 41.33 Bn 36.23 Bn 1.53 Bn 5.85 Mn
9 Revolution Medicines 41.30 Bn 41.30 Bn - -
10 Emergent BioSolutions 335.50 Mn 194.60 Mn 137.20 Mn 200,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 200,000.00
Jun 30, 2025 100,000.00
Mar 31, 2025 38.10 Mn
Dec 31, 2024 300,000.00
Sep 30, 2024 7.60 Mn
Mar 31, 2012 11.77 Mn
API Access

Emergent BioSolutions Sales of Property, Plant and Equipment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sales-of-property-plant-and-equipment&ticker=EBS&period=max&api_key=YOUR_API_KEY